Sacituzumab
gilead sciences
['breast', 'bcsm']
sactiuzumab govitecan produces significant efficacy benefits in pretreated hr+/her2- metastatic breast cancer #esmo2022 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.